We officially enrolled the first patient in Fib-CAS prospect Study! This collaborative multicenter AHA-funded prospective study explores the optimal antithrombotic strategies for stroke prevention in patients with sICAS and AF. Emory University Emory & Grady Vascular Neurology MUSC MIND Yale Neuroscience

International Stroke Conference 2025 #ISC2025 #MUSC #Neurology #Stroke

American Academy of Neurology #AAN2025 #MUSC #SanDiego #California

Join us for the MUSC Neurology Open House 🧠🏝️#MUSC #Neurology || lnkd.in/e-Ez4_j4

Interesting analysis from RESCU ICAS led by ⁦Matt Bender⁩ . Worse NIHSS on presentation and higher number of passes are strong predictors for futile recanalization, while stenting and complete recan provide protective effect

Excellent results with new clinical trials over the last three years indicate that there is no longer a need to delay anticoagulation for 1–2 weeks 🧠🏥 || #Stroke #VascularNeurology #Afib #Neurology linkedin.com/posts/alexvoro…

High blood pressure is the most prevalent and modifiable risk factor for the development of cardiovascular diseases, including coronary artery disease, heart failure, atrial fibrillation, stroke, dementia, chronic kidney disease, and all-cause mortality. This reflects several

Just out: The transition of the MUSC system to TNK with comparable safety and functional outcomes. Thanks to the great MUSC team Marina Buciuc Sami Al Kasab and my mentor Ghada A Mohamed. || 🏥🧠 strokejournal.org/article/S1052-…

2025 AHA Guidelines – Key Updates in Vascular Neurology 🧠📑 🔹 After successful EVT for LVO: lowering SBP <140 in the first 24–72h may worsen long-term outcomes (Class III: Harm).
🔹 Acute spontaneous ICH w/ SBP >220: avoid reducing below 130 (Class III: Harm).
🔹 Acute ICH w/

Published — even in 2025, vasculitis keeps challenging us at every step: from diagnosis to treatment 🧠 🏥 neurology.org/doi/10.1212/WN…

Expanding this to sites at Yale and MUSC with the amazing Alexander Vorobyev, MD and talented Akash Chakravartty on the team now thanks to the #AANAM Shark Tank! If interested in bringing this to your institution and helping yiur residents thrive, DM me! #meded #medtwitter American Academy of Neurology

Clinical Reasoning: A 56-Year-Old Woman With Right-Sided Weakness and Recurrent MRI Lesions hubs.la/Q03SgmFm0 #NeurologyRF

Presented at #SVIN25: CREST-2: In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: nej.md/3LK9kst Editorial:

2026 AHA/ASA Acute Ischemic Stroke Guidelines are LIVE! 🧠🏥 IVT now officially supported with unknown LKW and 9-hour window. A game-changer for stroke care protocols! #AHA #ASA #Stroke ahajournals.org/doi/10.1161/ST…

Excited to kick off #ISC26 with AHA Science — a week of cutting-edge stroke science 🧠 #MUSC #Stroke #ISC #Neurology

Representing #MUSC at #ISC26 AHA Science Stroke AHA/ASA

Great results from CHOICE II at #ISC26 — adjunct alteplase after MT shows benefit. #Stroke

#OCEANIC-STROKE just presented at #ISC26  showing #Asundexian is associated with reduced #ischemic #stroke in patients with non-cardioembolic stroke or high risk #TIA receiving antiplatelet therapy! AHA Science Stroke AHA/ASA SVIN Stroke: Vascular and Interventional Neurology JAHA

🚨 #ISC26 delivered BIG for stroke care. Multiple practice-important and promising trials across thrombosis, reperfusion, EVT, ICH, and neuroprotection 🏥🧠👇 🔹 OCEANIC-STROKE – Positive phase III: FXIa inhibition with asundexian reduced ischemic stroke in patients with